Dr. Ian J. Okazaki, MD

  • Honolulu, HI
  • Hematologist and oncologist
NPI1841304409PAC ID5496883548
Medicare services, 2024
213
Medicare patients, 2024
150
Part D claims, 2024
973
Publications
4
Clinical trials
1
Practice address
888 S King Street, Honolulu, HI 96813
Practice phone
Call (808) 522-4000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Straub Benioff Medical Center

Hospital · Honolulu, Hawaii

See all 16 affiliations

Find Dr. Okazaki's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Ian J. Okazaki is a hematologist and oncologist in Honolulu, Hawaii

Dr. Okazaki practices at Straub Benioff Medical Center in Honolulu, Hawaii, part of Hawaiʻi Pacific Health.

Dr. Okazaki's NPI, 1841304409, was assigned on August 19, 2006. Dr. Okazaki graduated from University of Hawaii John A. Burns School of Medicine in 1985. Dr. Okazaki holds Hawaii license MD-12319.

NPI and contact details
Medicare PAC ID
5496883548
NPI enumeration date
August 19, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(808) 522-4000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
67
Medical school graduation
1985

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Ian J. Okazaki practices at Straub Benioff Medical Center in Honolulu, Hawaii

Dr. Okazaki's primary practice is Straub Benioff Medical Center, at 888 S King Street, Honolulu, HI 96813 in Honolulu County. The practice phone is (808) 522-4000.

Source: Dmand AI Affiliation Data

Dr. Ian J. Okazaki is affiliated with 10 sites of care and 6 medical groups

Dr. Okazaki's primary practice is Straub Benioff Medical Center in Honolulu, Hawaii, part of Hawaiʻi Pacific Health. Dr. Okazaki is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is Straub Benioff Medical Center. Dmand AI also links Dr. Okazaki to 3 more hospitals, 5 medical groups, 4 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

See all 16 affiliations for Dr. Okazaki

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Ian J. Okazaki's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Okazaki practices, 10 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Straub Benioff Medical CenterAvailable with a free account
+9 more sites and 5 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Okazaki practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Hawaiʻi Pacific Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Ian J. Okazaki is one of 61 hematologists and oncologists in Hawaii

Hematology and oncology is Dr. Okazaki's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Okazaki is licensed in Hawaii.

Specialties and state licenses

  • Hematology and oncology, HawaiiPrimaryLicense MD-12319 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Okazaki

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Ian J. Okazaki billed Medicare for 213 services in 2024

CMS data shows 213 Medicare services from Dr. Okazaki across 4 procedure codes in 2024, all of them office visits, for 150 Medicare patients. Medicare paid $17,524 for them.

Medicare services, 2024213
Medicare patients150
Paid by Medicare$17,524
Procedure codes4

Dr. Okazaki's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 9282024: 21377%

Where Dr. Okazaki's Medicare services took place, 2024

  • In an office10650%
  • In a facility10750%

Dr. Okazaki compared with the Hawaii median for hematologists and oncologists, 2024

  • Dr. Okazaki
  • Hawaii median
Medicare services
213vs 36141% below
Medicare patients
150vs 19925% below
Part D claims
714vs 57025% above

Medians across 56 hematologists and oncologists in Hawaii with Dmand AI profiles that report each measure.

Dr. Okazaki's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Okazaki

Need commercial claims for Dr. Okazaki?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Okazaki and other hematologists and oncologists in Hawaii.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Ian J. Okazaki treated 150 Medicare patients in 2024, average age 75

CMS counts 150 Medicare patients who saw Dr. Okazaki in 2024. The largest group is 75 to 84, with 65 patients. 71% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Okazaki's median patient age at 75, with 22% women.

Medicare patients, 2024150
Average age75
Average risk score2.47

Dr. Okazaki's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Okazaki's Medicare patients by sex, 2024

  • Women4228%
  • Men10872%

Chronic conditions among Dr. Okazaki's Medicare patients, 2024

  1. High blood pressure71%
  2. High cholesterol70%
  3. Cancer66%
  4. Chronic kidney disease35%
  5. Arthritis33%
  6. Diabetes29%
  7. Ischemic heart disease22%
  8. Anxiety21%

Share of Medicare patients with each condition. A patient can have several.

Dr. Okazaki's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 75

Patient panel by sex, all payers

  • Women22%
  • Men78%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Ian J. Okazaki wrote 973 Medicare Part D claims in 2024

In 2024, Dr. Okazaki wrote 973 Medicare Part D claims for 235 patients. 75% of them were for generic drugs. CMS names the drug for 714 of them, across 15 drugs with 11 or more claims each, at $2,770,603 in total drug cost. In 2023, CMS named 1,647 claims across 33 drugs.

Part D claims, 2024973
Drugs named by CMS15
Total drug cost$2.8M
Part D patients235

Dr. Okazaki's Part D claims by kind of drug, 2024

  • Generic730 claims75%
  • Brand-name243 claims25%

Dr. Okazaki's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Okazaki's Part D claims, 2024

  • Opioids3%25 of 973 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,6472024: 71457%

Drugs named by CMS: 15 in 2024, 33 in 2023.

See all prescribing by Dr. Okazaki

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Ian J. Okazaki scored 89 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Okazaki for performance year 2024, reported as part of a group. Dr. Okazaki accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Okazaki as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Okazaki's MIPS scores, performance year 2024

  • 89of 100Final score
  • 75.4of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 76of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Okazaki by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Ian J. Okazaki has 4 publications on record

Dmand AI links 4 papers to Dr. Okazaki, published from 2014 to 2024. Dr. Okazaki's most frequent co-authors are Sunandana Chandra, MD, Jeffrey A. Sosman, MD and Charles L. Bane, MD.

Papers4
Years published2014 to 2024

Dr. Okazaki's papers by year, 2014 to 2024

Dr. Okazaki's most frequent co-authors

Recent publications by Dr. Okazaki

See all 4 publications and co-authors

See who Dr. Okazaki researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Okazaki works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Ian J. Okazaki has worked on 1 clinical trial

Dmand AI links Dr. Okazaki to 1 clinical trial. 1 is still active or recruiting.

Investigators on the most trials with Dr. Okazaki

Recent clinical trials with Dr. Okazaki

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Ian J. Okazaki received $1,265 in industry payments from 2016 to 2024

CMS Open Payments shows 58 general payments to Dr. Okazaki from 13 drug and device companies from 2016 to 2024. Education make up the largest share, 53% of the total. Pfizer Inc. paid the most, $551.

General payments to Dr. Okazaki by program year, 2016 to 2024

General payments to Dr. Okazaki by kind, 2016 to 2024

$1.3Kin total
  • Education$67353%
  • Food and beverage$59247%

Companies that paid Dr. Okazaki the most, 2016 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Okazaki

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Ian J. Okazaki graduated from University of Hawaii John A. Burns School of Medicine

Dr. Okazaki graduated from University of Hawaii John A. Burns School of Medicine in 1985.

  1. Medical schoolUniversity of Hawaii John A. Burns School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Ian J. Okazaki's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Ian J. Okazaki

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Ian J. Okazaki's NPI number?

Dr. Ian J. Okazaki's NPI number is 1841304409. It was assigned on August 19, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Ian J. Okazaki?

Dr. Ian J. Okazaki is a hematologist and oncologist in Honolulu, Hawaii. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Ian J. Okazaki practice?

Dr. Okazaki practices at 888 S King Street, Honolulu, HI 96813. Dr. Okazaki's primary practice is Straub Benioff Medical Center in Honolulu, Hawaii, part of Hawaiʻi Pacific Health. Dmand AI also links Dr. Okazaki to 3 hospitals, 5 medical groups, 4 group practices and clinics and 1 ambulatory surgery center.

What is Dr. Ian J. Okazaki's office phone number?

The practice phone on file for Dr. Okazaki is (808) 522-4000.

What is Dr. Ian J. Okazaki's medical license number?

Dr. Okazaki holds Hawaii license MD-12319.

Which hospitals is Dr. Ian J. Okazaki affiliated with?

Dr. Okazaki practices at Straub Benioff Medical Center in Honolulu, Hawaii. Dr. Okazaki is also affiliated with M Health Fairview University of Minnesota Medical Center. Dmand AI links Dr. Okazaki to 3 more hospitals.

What medical group is Dr. Ian J. Okazaki part of?

Dr. Okazaki is linked to Straub Benioff Medical Center. Dmand AI links Dr. Okazaki to 5 more medical groups.

Does Dr. Ian J. Okazaki accept Medicare?

Yes. CMS data shows Dr. Okazaki billed Medicare for 213 services in 2024, and Dr. Okazaki accepts Medicare assignment.

Does Dr. Ian J. Okazaki offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Okazaki as offering telehealth services.

What is Dr. Ian J. Okazaki's MIPS score?

Dr. Okazaki's MIPS final score for performance year 2024 is 89 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Ian J. Okazaki see?

CMS counts 150 Medicare patients who saw Dr. Okazaki in 2024, with an average age of 75.

What services does Dr. Ian J. Okazaki bill to Medicare?

In 2024, Dr. Okazaki's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, new patient (99205).

Where did Dr. Ian J. Okazaki go to medical school?

Dr. Okazaki graduated from University of Hawaii John A. Burns School of Medicine in 1985.

What drugs does Dr. Ian J. Okazaki prescribe most?

In 2024 Medicare Part D data, Dr. Okazaki's most prescribed drugs by claims were Abiraterone Acetate, Prednisone and Xtandi.

Has Dr. Ian J. Okazaki received payments from drug or device companies?

CMS Open Payments shows $1,265 in general payments to Dr. Okazaki from 13 companies from 2016 to 2024. The largest total came from Pfizer Inc.

How long has Dr. Ian J. Okazaki been practicing?

Dr. Okazaki graduated from medical school in 1985, 41 years ago.

Does Dr. Ian J. Okazaki do research?

Dmand AI links 4 publications to Dr. Okazaki, published from 2014 to 2024. Dr. Okazaki has worked on 1 clinical trial.

Who does Dr. Ian J. Okazaki publish with?

Dr. Okazaki's most frequent co-authors are Sunandana Chandra, MD (2 shared papers), Jeffrey A. Sosman, MD (2 shared papers) and Charles L. Bane, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Hawaii by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)